<DOC>
	<DOCNO>NCT01159899</DOCNO>
	<brief_summary>The purpose pilot study investigate efficacy safety autologous transplantation , arthroscopy , Bone Marrow Mesenchymal stem cell , use , cell separator , fresh non-culture expand Autologous Bone Marrow derive Mesenchymal Stem , mixed activate protein scaffold patient Knee cartilage defect osteoarthritis . Based extensive preclinical investigation , technology use freshly isolate bone marrow mononuclear cell mixed protein seem safe effective one-step correction cartilage defect restoration osteochondral complex , mixture generate cartilage vasculature-free knee joint , bone environment bone defect .</brief_summary>
	<brief_title>Transplantation Bone Marrow Stem Cells Stimulated Proteins Scaffold Heal Defects Articular Cartilage Knee</brief_title>
	<detailed_description>Before implantation mesenchymal stem cell , knee arthroscopy procedure make debridement meniscal cartilage lesion , microperforation abrasion , preparation osteochondral defect receive transplantation , patellar lateral release necessary . Then , investigator use fresh non-culture expand autologous bone marrow derive mesenchymal mononuclear stem cell , stimulate protein matrix mixed collagen hydroxyapatite scaffold . This cellular paste transplant prepared defect , arthroscopy , injection platelet rich plasma .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Osteonecrosis</mesh_term>
	<mesh_term>Osteochondritis</mesh_term>
	<mesh_term>Osteochondritis Dissecans</mesh_term>
	<criteria>Active patient ( 30 75 year ) A localized osteochondral defect condyle and/or tibia grade 4 ( ICRS classification ) cartilage tibial surface grade 34 , size &lt; 34 cm2 , 3/4 meniscus present . Stable knee ; previous ligament reconstruction , stable A defect 1 4 cm2 , 6 cm2 , locate femoral condyle /or le 4 cm2 tibial plate , IKS score &lt; 75 . Kissing lesion admit Ability understand willingness sign consent form Patients young 30 year old 75 year Diffuse advance articular cartilage degeneration joint Axial malalignment , meniscal pathology , ligamentous instability relative contraindication deal primarily either concomitantly transplantation 1 2 stage procedure . Refusal patient address condition presence cartilage lesion criterion exclusion study , avoid impact knee pathology final result Existing infection around joint &amp; lesion infectious oncologic etiology . Debilitated patient . Immunocompromised patient . Patients autoimmune disorder &amp; systemic inflammatory disease . Preoperative poor neurological vascular status affect limb . Specific contraindication include use tobacco medication may impair cell proliferation , NSAIDs immunosuppressive drug . Patients must nicotinefree ( stop smoking ) prior procedure , study show oxidative effect smoke impairs cell function subsequent healing .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Osteoarthritis</keyword>
	<keyword>knee arthritis</keyword>
	<keyword>Knee arthrosis</keyword>
	<keyword>articular cartilage defect</keyword>
	<keyword>osteochondral defect</keyword>
	<keyword>mesenchymal stem cell</keyword>
	<keyword>stem cell</keyword>
	<keyword>cellules souches ,</keyword>
	<keyword>genou</keyword>
	<keyword>arthrose genou</keyword>
	<keyword>PRP platelet rich plasma</keyword>
	<keyword>thérapie cellulaire</keyword>
	<keyword>implantation cellules souches mésenchymateuses</keyword>
	<keyword>régénération cartilage</keyword>
	<keyword>cicatrisation ménisque</keyword>
	<keyword>ligament</keyword>
	<keyword>plasma riche plaquettaire</keyword>
	<keyword>platelet rich plasma</keyword>
	<keyword>stem cell</keyword>
	<keyword>regrowt cartilage</keyword>
	<keyword>cellules souches</keyword>
	<keyword>PRP</keyword>
</DOC>